UniversalProcon

United Drug announces event management acquisition

01/12/2010

Our parent company, United Drug PLC, has announced a major addition to its rapidly expanding event management capability. Yesterday, 30 November 2010, United Drug has acquired WorldEvents Group, the global group of event management companies headed by WorldEvents Group Limited. We are delighted to welcome our fellow event management business into the United Drug CSMS (Contract Sales and Marketing Services) Division, alongside UniversalProcon.
Like UniversalProcon, WorldEvents is one of the UK’s top five event management businesses, specialising in the healthcare/pharmaceutical sector. Established over 20 years ago, the business has gone from strength to strength, now operating successfully across the globe.
Yesterday’s acquisition sees United Drug owning two of the UK’s top five events management businesses, demonstrating United Drug’s continued confidence in and commitment to this sector.
To read the official press release and for more information on United Drug PLC please follow the link below.

Press Release

For further information please contact Lynsey Collier, Sales and Communications Manager at UniversalProcon on 01530 562 462 or email : lynsey.collier@universalprocon.com

Continued growth sees UniversalProcon appoint new UK Country Manager

29/11/2010

Due to continued growth and recent new business wins, UniversalProcon has appointed Denise Abbott to the newly created role of UK Country Manager. Abbott joins UniversalProcon from sister company Ashfield In2Focus, part of the CSMS Division of United Drug, where her most recent roles include Head of Operations, Head of Resourcing and Head of Training. With over 11 year’s experience spent predominately in senior managerial roles within the highly successful contract services organisation, Abbott brings a wealth of experience in dealing with contract delivery, business development support and maximizing efficiencies within the organisation. UniversalProcon have seen substantial growth in the UK; expanding existing client accounts but also through a significant number of new client wins. In nine months they have seen their client base grow from nine to 27 clients within the Pharmaceutical Industry. This is a result of a strategic focus on business development and delivering client excellence. Graham McIntosh, UniversalProcon’s Global Managing Director, comments: “I am delighted to welcome Denise to the UniversalProcon family; she has the expertise, analytical skills and client centric approach that will strengthen our UK operations. “Denise brings with her a wealth of pharmaceutical experience having worked within the industry for over 11 years in senior managerial roles. As UK Country Manager, she will be the lynch pin between the business development and the operations teams, ensuring a consistent and customer focused service for our clients whilst maintaining impeccable event delivery. “That Denise also has a proven track record as Head of Resourcing will be invaluable as we continue our recruitment drive and strengthen our operations teams in order to service growing business demand.”

For further information contact : Lynsey Collier, Sales and Communications Manager at UniversalProcon
Tel: +44 (0)1530 562462
Mobile: +44 (0)7872 507442
Email: Lynsey.collier@universalprocon.com

UniversalProcon expands following business wins

13/09/2010

UniversalProcon has expanded its UK meetings and events division following new business wins with clients including Novartis Vaccines, Allergan, Nutricia and Leo Pharma UK. The agency has appointed five new members of staff following account growth with existing healthcare clients and new business wins such as Grunenthal, Celgene, Astellas and Tri-Ductive.UniversalProcon global managing director Graham McIntosh said: "I am delighted at the success of our drive on new business; our investment in these new appointments is vital to ensure we continue to deliver the highest levels of customer service."
New appointments
New appointments include Sophie Limbert, who joins UniversalProcon as a project manager from P&MM.
Felicity Jackson has also been appointed as a project manager, and formerly worked at Zibrant.
Rohanna Burrow joins the operations team as an events project executive after spending two years in the agency’s venue-finding team.
Carly Moon and Lizzie Craig have also been appointed as event co-ordinators.

UniversalProcon names sales and communications manager

23/08/2010

UniversalProcon has appointed Lynsey Collier to the newly created role of sales and communications manager. Her remit will be to lead new business processes, including initial client communication and development of proposals and pitch presentations.Collier has more than six years experience in the events industry, most recently heading up the pitch team at Zibrant.
UniversalProcon global managing director Graham McIntosh said: "Lynsey brings a wealth of creative and technical expertise to our business. She will strategically build upon the great work already undertaken in developing integration between the business development, account management, venue-finding and operations teams, to deliver bespoke customer solutions rather than a 'one size fits all' approach."

UniversalProcon and Trifecta Multimedical® participate in ExL Pharma’s 2nd annual virtual conference, ClinXpo

22/09/2009

Stamford, CT, September 22, 2009: Dax Kiger, Director of Strategic Development at UniversalProcon (UP) and Trifecta MultiMedical® (TMM), lead a team exhibiting at ClinXpo, a virtual conference and exhibition for clinical development outsourcing, held on September 16, 2009.

ClinXpo is the premier on-line conference and tradeshow forum designed for pharmaceutical and biotechnology clinical development executives, CROs and other clinical service providers. UP and TMM showcased the suite of Certified Clinical Communication strategies specifically tailored for Clinical Research and Drug Development processes.

UP/TMM was among a dozen or so other exhibitors and hundreds of virtual attendees. Visitors could enter the virtual environment and browse through exhibitor booths viewing demonstrations, product reviews and engage with booth representatives to learn more about particular services. This is a new concept and one that aligns with the goals of both organizations (UP & TMM) highlighting virtual solutions via an entirely virtual environment.

Regarding the experience at the virtual conference, Mr. Kiger of UP had this to say, “ClinXpo was an amazing opportunity – it (ClinXpo) provided us a unique opportunity to have conversations with sponsors and clinical research organizations that see the value in utilizing the right technology solutions to enhance their communication activity. Our solutions are revolutionizing certified training of global sites engaged in a clinical trial. It was evident that the attendees at ClinXpo agree."

UniversalProcon is a United Drug company. UniversalProcon is an organization focused on meeting and event solutions in the healthcare industry. It is through Trifecta MultiMedical®, that certified web-based solutions are provided to service a growing need for unique strategies to clinical communication effectiveness.

To contact UniversalProcon and Trifecta MulitiMedical®:
Dax Kiger - Director, Strategic Development, dax.kiger@universalprocon.com, 203-570-1099
Julie Duffey - Manager, Strategic Development, julie.duffey@universalprocon.com, 203-391-5614

UniversalProcon to exhibit at MAGI Clinical Research Conference 2009 West Coast, in San Diego.

13/09/2009

Stamford, CT, September 13, 2009: Dax Kiger, Director of Strategic Development at UniversalProcon (UP) and Trifecta MultiMedical®, is to lead a team exhibiting at the MAGI West Coast Clinical Research Conference, held October 4-7, 2009 in San Diego, California.

MAGI’s mission is to standardize best practices for clinical research operations, business and regulatory compliance. MAGI holds two Clinical Research Conferences per year: one in the spring in the eastern U.S. and one in the fall in the western U.S. With over 3,000+ members representing most of the major players in the industry, the East coast event this past Spring, showed a 10% increase in attendance over last year. The conference will focus on contracts, budgets and regulatory, as well as two new tracks: sponsor operations and site operations, plus a major focus on investigator and subject recruiting.

UP’s primary presence at the 2009 MAGI West Coast will be to showcase the suite of Certified Clinical Communication strategies specifically tailored for Clinical Research and Drug Development processes. Visit Universal Procon’s Strategic Development team on the showroom floor and find out more about what UP can do through certified electronic communications to maximize the efficiency and effectiveness of your clinical research, studies and trials.

UniversalProcon is a United Drug company. UniversalProcon is an organization focused on meeting and event solutions in the healthcare industry. It is through Trifecta MultiMedical®, that electronic and certified solutions are provided to service a growing need for unique strategies to clinical communication effectiveness.

To contact UniversalProcon and Trifecta MulitiMedical®:
Dax Kiger - Director, Strategic Development, dax.kiger@universalprocon.com, 203-570-1099
Julie Duffey - Manager, Strategic Development, julie.duffey@universalprocon.com, 203-391-5614

UniversalProcon to exhibit at 2009 DIA 45th Annual Meeting in San Diego

19/06/2009

- Stamford, CT, June 19, 2009: Dax Kiger, Director of Strategic Development at UniversalProcon (UP), is to lead a team exhibiting at the DIA 45th Annual Meeting, held June 21 – 25, 2009 in San Diego, California.

- The DIA (Drug Information Association) Annual event is the biopharmaceutical industry's largest, longest running global and multidisciplinary event. This year’s meeting will host upwards of 8,000 clinical colleagues and feature hundreds of educational sessions and pre-conference tutorials focusing on issues affecting global drug discovery and development affecting key regions of the World.

- UP’s primary presence at the 2009 DIA Annual Meeting will be to showcase the suite of Certified Clinical Communication strategies specifically tailored for Clinical Research and Drug Development processes. Visit UniversalProcon’s Strategic Development team at booth #112 and find out more about what UP can help achieve through certified electronic communications to maximize the efficiency and effectiveness of your clinical research, studies and trials.

- UniversalProcon is a United Drug company focused on meeting and event solutions in the healthcare industry. It is through Trifecta MultiMedical, that electronic and certified solutions are provided to service a growing need of unique strategies for clinical communication effectiveness.

- To contact UniversalProcon:
Dax Kiger, Director, Strategic Development, dax.kiger@universalprocon.com, 203-570-1099
Julie Duffey, Manager, Strategic Development, julie.duffey@universalprocon.com, 203-391-5614

UniversalProcon broadens business development focus within meeting technology division with appointment of UK based sales and marketing executive

02/02/2009

Stamford, CT, January 27, 2009:  UniversalProcon (UP), owned by United Drug of Dublin, is a leading healthcare meeting and event solutions company in both the US and UK.  Trifecta MultiMedical (TMM) is the virtual meetings and technology division of UniversalProcon.  It is through the TMM arm that strategic virtual meeting solutions are provided to service a growing need for low cost, high tech meetings in the clinical and marketing arenas.

In an effort to further deepen TMM’s sales and marketing presence in the UK and Europe, a UK based sales and marketing executive has been appointed.  Rowenne Brockfield has been with UniversalProcon as a Project Manager on a major Pharma client for the past two and a half years.  Through her success in growing that account and with a full understanding of medical meetings and the challenges the industry faces, it was a natural move for Rowenne into a sales focused role.  Rowenne’s primary objective is to help support TMM’s growing presence in the UK and EU markets and to provide better strategic planning for those clients, existing and new.

UniversalProcon and Trifecta MultiMedical are looking forward to Rowenne’s role in the expansion of TMM’s products in the virtual meetings marketplace.

To contact UniversalProcon and Trifecta MulitiMedical, with questions about healthcare meetings and events or virtual meeting technologies:
Dax Kiger, Director of Strategic Development, dax.kiger@universalprocon.com
Julie Duffey, Manager of Strategic Development, julie.duffey@universalprocon.com

Universal CIT and Procon Conferences are to merge

15/08/2008

Coming together, for a brighter stronger future

From 1 October 2008, two United Drug companies within the Sales and Marketing Services Division, Universal CIT and Procon, will merge to form one company and become a powerful player in the world of healthcare event management.

Both companies offer expertise in their respective fields including venue finding, event logistics through to creative marketing, production and travel services. This move provides an exciting opportunity to combine the skills to offer a bigger, better and more complete service to new and existing clients.

The new company will be called UniversalProcon Ltd in the UK and UniversalProcon Inc in the US and will continue to operate from the two UK offices in Harrogate and Slough, as well as our three US offices in Stamford CT, Indianapolis IN and Orlando FL.

Speaking about the future, Mike Ford, Universal’s current Managing Director who will head up the soon to be renamed UniversalProcon said: “We truly believe that by coming together, UniversalProcon will be the leading healthcare full-service event management agency, providing a wider range of services to a growing audience spanning the UK, US, Europe and beyond. In the coming months we look forward to revealing our new brand identity to support our new look organisation.”

Universal CIT Ltd Acquired by United Drug PLC

01/01/2008

Leading pharma specialist agency Universal CIT Ltd has announced its acquisition by United Drug plc, a leading provider of services to the pharmaceutical industry in the UK, US, Ireland and Continental Europe.

In acquiring Universal, United Drug will add to its existing meetings and events offering, having acquired the Harrogate-based pharmaceutical conference service company Procon Conferences, in November 2007.

Speaking about the acquisition, United Drug Chief Executive, Liam FitzGerald said: “We are delighted to announce the acquisition of Universal. This acquisition allows us to further pursue our strategy of building a range of marketing related services around our core sales offering within the Contract Sales & Marketing Services division and continue to benefit from the trend amongst pharmaceutical manufacturers to outsource non-core functions.”

Under the new ownership, Universal will retain its name and brand. Its key management team will remain in place, as will its account teams.

Universal’s Managing Director Mike Ford commented; “Belonging to a larger group with such obvious synergies, will not only enhance our commercial positioning, but also strengthen our knowledge and involvement in the pharmaceutical sector.

“Universal is already the UK’s largest pharma agency specialist, but this move will substantially increase our potential for growth and development.”

Mike Ford went onto to add “As far as our focus and our client service delivery are concerned, it will be a matter of business-as-usual. In the medium and longer term, however, we are confident that our clients will benefit from an enhanced service offering through our broader geographical reach and consolidated purchasing power.”

Universal CIT Ltd has been organising international business events for over 30 years. The company currently employs more than 140 staff, with a UK head office in Slough and US bases in Stamford CT, Indianapolis and Orlando.